Departments of Orthopedics, Institute of Clinical Sciences, Skåne University Hospital in Lund, SE-22185 Lund, Sweden.
J Bone Joint Surg Am. 2012 Jul 18;94(14):1291-6. doi: 10.2106/JBJS.K.01271.
Optimal treatment of soft-tissue sarcoma requires multidisciplinary management at a sarcoma center. However, these rare tumors are often misinterpreted as benign and many are inadequately treated outside a sarcoma center, with an increased risk of local recurrence that often requires further extensive surgical treatment. To improve referral and centralization of soft-tissue sarcoma management in the southern Sweden health care region, an open-access outpatient clinic at our sarcoma center and simple referral guidelines have been established for the past thirty years. The guidelines call for referral of all deep-seated soft-tissue tumors and of all ≥5-cm superficial tumors before open biopsy or surgery. We evaluated adherence to these guidelines and characterized referral patterns. We also studied the consequences of our strategy with regard to the relative numbers of benign and malignant diagnoses among referred patients.
Adherence to guidelines, referral pathways, and time to referral to the sarcoma center were analyzed in a population-based series of 100 consecutive patients with soft-tissue sarcoma in the extremities or trunk wall. We also analyzed diagnosis and management of benign and malignant tumors in a second cohort consisting of 464 consecutive patients referred to the sarcoma center because of a soft-tissue tumor.
Ninety-seven of the 100 patients with soft-tissue sarcoma were referred to the sarcoma center. All fifty-eight of the deep-seated soft-tissue sarcomas and twenty-eight of the forty-two superficial tumors were referred before open biopsy or surgery. Three-quarters of the patients with soft-tissue sarcoma first presented to a general practitioner. One-quarter of these patients were directly referred to the sarcoma center, which cut the referral time in half compared with patients initially referred to a local hospital. One-quarter of all patients referred to the outpatient clinic were diagnosed with a malignancy, with the majority of the malignancies being soft-tissue sarcoma.
Our simple referral guidelines and open-access outpatient clinic resulted in nearly complete referral of patients with soft-tissue sarcoma to the sarcoma center. The "excess work" associated with referral of benign tumors according to our strategy was limited to the diagnosis of three benign tumors for each malignant tumor. We consider this surplus evaluation of benign tumors acceptable and probably necessary to achieve a high referral rate of soft-tissue sarcoma before initial surgery.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
软组织肉瘤的最佳治疗需要肉瘤中心的多学科管理。然而,这些罕见的肿瘤经常被误诊为良性,并且许多在肉瘤中心外治疗不当,局部复发风险增加,往往需要进一步广泛的手术治疗。为了改善瑞典南部卫生保健区软组织肉瘤管理的转诊和集中化,在过去三十年中,我们的肉瘤中心建立了一个开放门诊诊所和简单的转诊指南。该指南要求对所有深部软组织肿瘤和所有> 5 厘米的浅表肿瘤在开放活检或手术前进行转诊。我们评估了对这些指南的遵守情况,并描述了转诊模式。我们还研究了我们策略对转诊患者中良性和恶性诊断相对数量的影响。
在 100 例连续的四肢或躯干壁软组织肉瘤患者的基于人群的系列中,分析了对指南的遵守情况、转诊途径和转诊至肉瘤中心的时间。我们还分析了第二组 464 例因软组织肿瘤转诊至肉瘤中心的患者的良性和恶性肿瘤的诊断和管理。
100 例软组织肉瘤患者中有 97 例转诊至肉瘤中心。所有 58 例深部软组织肉瘤和 42 例浅表肿瘤中有 28 例在开放活检或手术前进行了转诊。四分之三的软组织肉瘤患者首先就诊于全科医生。其中四分之一的患者直接转诊至肉瘤中心,与最初转诊至当地医院的患者相比,转诊时间缩短了一半。四分之一转诊至门诊的患者被诊断为恶性肿瘤,其中大多数恶性肿瘤为软组织肉瘤。
我们简单的转诊指南和开放门诊诊所使几乎所有软组织肉瘤患者都转诊至肉瘤中心。根据我们的策略,转诊良性肿瘤的“额外工作”仅限于每例恶性肿瘤诊断出 3 例良性肿瘤。我们认为这种对良性肿瘤的多余评估是可以接受的,并且可能是在初始手术前实现软组织肉瘤高转诊率所必需的。
治疗性 III 级。请参阅作者说明,以获得完整的证据水平描述。